William Thomas's most recent trade in Sherwin-Williams Co. was a trade of 106 Common Stock done at an average price of $318.4 . Disclosure was reported to the exchange on April 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sherwin-Williams | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 318.39 per share. | 06 Apr 2026 | 106 | 1,162 (0%) | 0% | 318.4 | 33,749 | Common Stock |
| International Paper | William Thomas Hamic | Exec. VP & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.70 per share. | 01 Apr 2026 | 12,666 | 131,452 (0%) | 0% | 35.7 | 452,176 | Common Stock |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 59,801 | 59,801 | - | - | Employee Stock Option (right to buy) | |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 8,227 | 8,227 | - | - | Restricted Stock Units | |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.26 per share. | 18 Feb 2026 | 4,471 | 65,313 (0%) | 0% | 80.3 | 358,842 | Common Stock |
| Sherwin-Williams | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2026 | 558 | 2,371 (0%) | 0% | 0 | Common Stock | |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 15,883 | 69,784 (0%) | 0% | 0 | Common Stock | |
| International Paper | William Thomas Hamic | Exec. VP & President | Grant, award, or other acquisition of securities at price $ 46.58 per share. | 09 Feb 2026 | 43,225 | 159,430 (0%) | 0% | 46.6 | 2,013,421 | Common Stock |
| International Paper | William Thomas Hamic | Exec. VP & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.58 per share. | 09 Feb 2026 | 15,312 | 144,118 (0%) | 0% | 46.6 | 713,233 | Common Stock |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.16 per share. | 04 Feb 2026 | 3,013 | 56,537 (0%) | 0% | 65.2 | 196,327 | Common Stock |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2026 | 3,013 | 0 | - | - | Employee Stock Option (right to buy) | |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.49 per share. | 04 Feb 2026 | 2,636 | 53,901 (0%) | 0% | 78.5 | 206,900 | Common Stock |
| International Paper | William Thomas Hamic | Exec. VP & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.32 per share. | 01 Feb 2026 | 1,406 | 117,476 (0%) | 0% | 40.3 | 56,690 | Common Stock |
| International Paper | William Thomas Hamic | Exec. VP & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.32 per share. | 01 Feb 2026 | 1,271 | 116,205 (0%) | 0% | 40.3 | 51,247 | Common Stock |
| Sherwin-Williams | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 347.95 per share. | 09 Jan 2026 | 97 | 1,053 (0%) | 0% | 347.9 | 33,751 | Common Stock |
| Sherwin-Williams | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 344.41 per share. | 03 Oct 2025 | 98 | 953 (0%) | 0% | 344.4 | 33,752 | Common Stock |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Purchase of securities on an exchange or from another person at price $ 68.73 per share. | 27 Aug 2025 | 3,670 | 53,524 (0%) | 0% | 68.7 | 252,239 | Common Stock |
| Capital Southwest Corp | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 2,193 | 18,344 (0%) | 0% | 0 | Common Stock | |
| Veralto | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 2,265 | 5,860 | - | - | Director Stock Option (Right to Buy) | |
| Veralto | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 818 | 2,371 | - | 0 | Common Stock | |
| Sherwin-Williams | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 347.96 per share. | 07 Jul 2025 | 97 | 853 (0%) | 0% | 348.0 | 33,752 | Common Stock |
| Hanmi Fin Corp | Thomas J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 2,849 | 26,325 (0%) | 0% | 0 | Common Stock | |
| Sprout Social Inc (Class A) | William Thomas Stanley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 8,298 | 23,647 (0%) | 0% | 0 | Class A Common Stock | |
| NOV Inc | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 15,949 | 91,709 (0%) | 0% | 0 | Common Stock | |
| Sherwin-Williams | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 340.92 per share. | 04 Apr 2025 | 99 | 754 (0%) | 0% | 340.9 | 33,751 | Common Stock |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 28,919 | 28,919 | - | - | Employee Stock Option (right to buy) | |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 5,523 | 5,523 | - | - | Restricted Stock Units | |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 1,963 | 0 | - | - | Employee Stock Option (right to buy) | |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.46 per share. | 20 Feb 2025 | 1,963 | 51,817 (0%) | 0% | 74.5 | 146,165 | Common Stock |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Sale of securities on an exchange or to another person at price $ 101.00 per share. | 20 Feb 2025 | 1,963 | 49,854 (0%) | 0% | 101 | 198,263 | Common Stock |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 19,331 | 56,021 (0%) | 0% | 0 | Common Stock | |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.47 per share. | 18 Feb 2025 | 6,167 | 49,854 (0%) | 0% | 103.5 | 638,099 | Common Stock |
| Sherwin-Williams | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 517 | 1,813 (0%) | 0% | 0 | Common Stock | |
| International Paper | William Thomas Hamic | Exec. VP & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 32,597 | 130,516 (0%) | 0% | 0 | Common Stock | |
| International Paper | William Thomas Hamic | Exec. VP & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.07 per share. | 10 Feb 2025 | 11,629 | 118,887 (0%) | 0% | 56.1 | 652,038 | Common Stock |
| International Paper | William Thomas Hamic | Exec. VP & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.63 per share. | 03 Feb 2025 | 1,324 | 97,919 (0%) | 0% | 55.6 | 73,654 | Common Stock |
| International Paper | William Thomas Hamic | Exec. VP & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.63 per share. | 03 Feb 2025 | 1,199 | 99,243 (0%) | 0% | 55.6 | 66,700 | Common Stock |
| Sherwin-Williams | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 337.51 per share. | 03 Jan 2025 | 100 | 652 (0%) | 0% | 337.5 | 33,751 | Common Stock |
| Sherwin-Williams | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 375.00 per share. | 04 Oct 2024 | 90 | 551 (0%) | 0% | 375 | 33,750 | Common Stock |
| Capital Southwest Corp | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 2,090 | 16,151 (0%) | 0% | 0 | Common Stock | |
| Veralto | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 2,005 | 3,595 | - | - | Director Stock Option (Right to Buy) | |
| Veralto | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 842 | 1,553 | - | 0 | Common Stock | |
| Sherwin-Williams | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 296.07 per share. | 05 Jul 2024 | 114 | 459 (0%) | 0% | 296.1 | 33,752 | Common Stock |
| International Paper | William Thomas Hamic | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 30,000 | 99,211 (0%) | 0% | 0 | Common Stock | |
| Capital Southwest Corp | William R. Thomas | Director | Purchase of securities on an exchange or from another person at price $ 25.87 per share. | 03 Jun 2024 | 9,400 | 14,061 (0%) | 0% | 25.9 | 243,139 | Common Stock |
| Capital Southwest Corp | William R. Thomas | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 8,217 | 4,661 (0%) | 0% | 0 | Common Stock | |
| Provident Financial Holdings | William E. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 10,000 | 10,000 | - | - | Option to purchase Common Stock | |
| Sprout Social Inc (Class A) | William Thomas Stanley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 5,612 | 15,349 (0%) | 0% | 0 | Class A Common Stock | |
| Hanmi Fin Corp | Thomas J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 4,040 | 23,476 (0%) | 0% | 0 | Common Stock | |
| NOV Inc | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 9,550 | 75,760 (0%) | 0% | 0 | Common Stock | |
| Encore Wire Corp | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 1,250 | 13,600 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Sherwin-Williams | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 334.15 per share. | 05 Apr 2024 | 101 | 344 (0%) | 0% | 334.1 | 33,749 | Common Stock |
| Kinnate Biopharma Inc | Richard Thomas Williams | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.59 per share. | 01 Mar 2024 | 558 | 67,588 | - | 2.6 | 1,445 | Common Stock |
| Eastman Chemical | Thomas William McLain | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 26,756 | 26,756 | - | - | Employee Stock Option (right to buy) | |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 5,416 | 5,416 | - | - | Restricted Stock Units | |
| Eastman Chemical | William Thomas McLain | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.12 per share. | 14 Feb 2024 | 2,698 | 36,690 (0%) | 0% | 82.1 | 221,560 | Common Stock |
| Sherwin-Williams | Thomas Williams L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 594 | 1,296 (0%) | 0% | 0 | Common Stock | |
| International Paper | William Hamic Thomas | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 13,789 | 72,073 (0%) | 0% | 0 | Common Stock | |
| International Paper | Thomas William Hamic | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.26 per share. | 12 Feb 2024 | 3,358 | 68,715 (0%) | 0% | 35.3 | 118,403 | Common Stock |
| International Paper | Hamic William Thomas | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.83 per share. | 01 Feb 2024 | 1,319 | 58,284 (0%) | 0% | 35.8 | 47,260 | Common Stock |
| Sherwin-Williams | L. Thomas Williams | Director | Grant, award, or other acquisition of securities at price $ 298.67 per share. | 05 Jan 2024 | 113 | 242 (0%) | 0% | 298.7 | 33,750 | Common Stock |
| International Paper | Thomas William Hamic | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 14,419 | 59,603 (0%) | 0% | 0 | Common Stock | |
| Kinnate Biopharma Inc | Thomas Williams Richard | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.25 per share. | 01 Dec 2023 | 541 | 68,146 | - | 2.2 | 1,217 | Common Stock |
| Sherwin-Williams | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 253.90 per share. | 06 Oct 2023 | 128 | 128 (0%) | 0% | 253.9 | 32,499 | Common Stock |
| Parker-Hannifin | Thomas L. Williams | Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2023 | 11,580 | 11,580 | - | - | Stock Appreciation Rights | |
| Capital Southwest Corp | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 2,240 | 12,878 (0%) | 0% | 0 | Common Stock | |
| Gevo Inc | Geoffrey Thomas Williams | VP-General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 96,420 | 96,420 | - | - | Stock Option | |
| Gevo Inc | Geoffrey Thomas Williams | VP-General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 96,420 | 455,530 (3%) | 0% | 0 | Common Stock | |
| Gevo Inc | Geoffrey Thomas Williams | VP-General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 1.65 per share. | 28 Jul 2023 | 12,496 | 359,110 (2%) | 0% | 1.6 | 20,603 | Common Stock |
| Sherwin-Williams | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 702 | 702 (0%) | 0% | 0 | Common Stock | |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.30 per share. | 01 Jun 2023 | 541 | 69,228 | - | 4.3 | 2,326 | Common Stock |
| Hanmi Fin Corp | Thomas J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 4,334 | 19,436 (0%) | 0% | 0 | Common Stock | |
| Sprout Social Inc (Class A) | William Thomas Stanley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 3,895 | 9,737 (0%) | 0% | 0 | Class A Common Stock | |
| NOV Inc | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 12,000 | 66,210 (0%) | 0% | 0 | Common Stock | |
| Encore Wire Corp | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 1,250 | 12,350 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Parker-Hannifin | Thomas L. Williams | Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 48,887 | 227,914 (0%) | 0% | 0 | Common Stock | |
| Parker-Hannifin | Thomas L. Williams | Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.65 per share. | 27 Apr 2023 | 22,658 | 255,256 (0%) | 0% | 311.7 | 7,061,366 | Common Stock |
| Goodyear Tire & Rubber Co. | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2023 | 15,139 | 67,750 | - | - | Restricted Stock Units | |
| Goodyear Tire & Rubber Co. | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,663 | 52,611 | - | - | Restricted Stock Units | |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.21 per share. | 01 Mar 2023 | 638 | 67,295 | - | 5.2 | 3,324 | Common Stock |
| Eastman Chemical | William Thomas McLain | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 28,236 | 28,236 | - | - | Employee Stock Option (right to buy) | |
| Eastman Chemical | William Thomas McLain | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 14,519 | 32,402 (0%) | 0% | 0 | Common Stock | |
| Eastman Chemical | William Thomas McLain | SVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.09 per share. | 15 Feb 2023 | 4,044 | 28,358 (0%) | 0% | 89.1 | 360,280 | Common Stock |
| Parker-Hannifin | Thomas L. Williams | Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2023 | 105,500 | 0 | - | - | Stock Appreciation Rights | |
| Parker-Hannifin | Thomas L. Williams | Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 124.36 per share. | 13 Feb 2023 | 105,500 | 334,527 (0%) | 0% | 124.4 | 13,119,980 | Common Stock |
| Parker-Hannifin | Thomas L. Williams | Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 353.36 per share. | 13 Feb 2023 | 67,402 | 267,125 (0%) | 0% | 353.4 | 23,817,171 | Common Stock |
| Parker-Hannifin | Thomas L. Williams | Executive Chairman | Sale of securities on an exchange or to another person at price $ 352.63 per share. | 13 Feb 2023 | 38,098 | 229,027 (0%) | 0% | 352.6 | 13,434,498 | Common Stock |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 215,000 | 215,000 | - | - | Employee Stock Option (right to buy) | |
| International Paper | William Thomas Hamic | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 12,008 | 34,058 (0%) | 0% | 0 | Common Stock | |
| International Paper | William Thomas Hamic | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.85 per share. | 03 Feb 2023 | 3,059 | 30,999 (0%) | 0% | 40.8 | 124,960 | Common Stock |
| Goodyear Tire & Rubber Co. | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 3,925 | 48,948 | - | - | Restricted Stock Units | |
| International Paper | William Thomas Hamic | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 13,449 | 45,012 (0%) | 0% | 0 | Common Stock | |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.75 per share. | 01 Dec 2022 | 541 | 67,933 | - | 7.8 | 4,193 | Common Stock |
| Goodyear Tire & Rubber Co. | Thomas L. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 3,756 | 45,023 | - | - | Restricted Stock Units | |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 25,000 | 68,474 | - | 0 | Common Stock | |
| Gevo Inc | Geoffrey Thomas Williams | VP-General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 3.08 per share. | 22 Aug 2022 | 18,041 | 371,606 (2%) | 0% | 3.1 | 55,629 | Common Stock |
| EOG Resources | William R. Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 69,969 | 0 | - | - | Stock Appreciation Rights | |
| EOG Resources | William R. Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 96.29 per share. | 18 Aug 2022 | 69,969 | 782,666 (0%) | 0% | 96.3 | 6,737,315 | Common Stock |
| EOG Resources | William R. Thomas | Director | Sale or transfer of securities back to the company at price $ 116.70 per share. | 18 Aug 2022 | 57,732 | 724,934 (0%) | 0% | 116.7 | 6,737,324 | Common Stock |
| EOG Resources | William R. Thomas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 116.70 per share. | 18 Aug 2022 | 4,816 | 720,118 (0%) | 0% | 116.7 | 562,027 | Common Stock |
| Parker-Hannifin | Thomas L. Williams | Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 70,620 | 70,620 | - | - | Stock Appreciation Rights |